|
Will Bosh be allowed to play and take blood thinners?: With the Heat’s Chris Bosh, conversations are continuing regarding potential use of blood thinners that could be out of his system by game time. It remains undecided if the Heat will be OK with that approach (they weren't when he suggested that last spring) or whether they will clear him to play. There are mixed opinions in the medical community about whether a player who has had two clotting episodes in the span of a year (but doesn't have the gene that makes him pre-disposed to clotting) should remain on blood thinners beyond the normal six-month cycle. Bosh falls into that category. -- The Miami Herald Did moving with haste bloat Heat roster?: NBA free agency is never a straight line, a clean path to the most efficient use of cap space and roster real estate. It also is not a path that allows for U-turns, detours, backtracking. Because if the Miami Heat knew then, during the franchise's most frantic stages of 2016 free agency, what they know now, this 19-player offseason mix might not only be reshuffled, it might not even be bloated to within one player of the NBA offseason limit. -- South Florida Sun-Sentinel Spoelstra on Whiteside: 'Absorb more minutes, more responsibility, more games': More than a month from the start of training camp, Miami Heat coach Erik Spoelstra has put forward a blueprint for Hassan Whiteside's new reality as a $98 million player. In the latest of his videos posted on the team's website, Spoelstra spoke of the need to maximize the possibilities of his shot-blocking center, including additional post-up responsibilities and great accountability away from the rim. -- South Florida Sun-Sentinel
|
